Events and announcements 

• Cannabis use and the developing brain (Hazelden Betty Ford) - Mar. 26 from noon to 1 p.m. 

• Zeroing in on xylazine (Grayken Center for Addiction Training & Technical Assistance) - Mar. 26 from 2 to 3 p.m. 

• Navigating cannabis legalization: Strategies for a local prevention response (PTTC) - Apr. 8 from noon to 1:30 p.m. 

• Environmental scans: Tools for alcohol and cannabis prevention (Prevention First) - May 6 from 10 to 11 a.m. 

• Proposed menthol rules withdrawn: Litigation continues (Public Health Law Center) 

• Open grant opportunities (MDH). Two Request for Proposal (RFP) funding opportunities for substance use prevention recently opened.  

New resources! 

• Commercial tobacco-free K-12 school model policy (PDF) (Public Health Law Center) 

Data and research 

• Notes from the field: Tobacco product use among adults — United States, 2017–2023 (MMWR) 

• Flavored e-cigarette sales restrictions and young adult tobacco use (JAMA Network) 

• Daily or nondaily vaping and smoking cessation among smokers (JAMA Network) 

• Messages about tobacco and alcohol co-users (Journal of Studies on Alcohol and Drugs) 

• How does removing menthol tobacco product displays at point-of-sale affect adolescents’ cigarette smoking intentions? The mediating effects of social norms (Journal of Behavioral Medicine) 

• Alcohol-associated pancreatitis and liver disease among adolescents and young adults (JAMA Network) 

• Age of onset of adolescent alcohol use with parental permission and its impact on drinking and alcohol-harms in young adulthood: A longitudinal study (Addictive Behaviors) 

• Disaggregating trends in alcohol involvement among Hispanic, Black, and White female and male U.S. adolescents: 2002 to 2019 (Journal of Studies on Alcohol and Drugs) 

• Acute alcohol use and suicide (JAMA Network) 

• Association of substance use with suicide mortality: An updated systematic review and meta-analysis (Drug and Alcohol Dependence Reports) 

• Characteristics and effects of cannabis advertisements with appeal to youth in California (International Journal of Drug Policy) 

• The longitudinal association of cumulative depression with cannabis use disorder among young adults (Journal of Studies on Alcohol and Drugs) 

• The recent trend of twin epidemic in the United States: A 10-year longitudinal cohort study of co-prescriptions of opioids and stimulants (The Lancet Regional Health – Americas) 

• Naloxone knowledge, carrying, purchase, and use (JAMA Network) 

• What are the risk factors of non-fatal overdose among persons who use opioids? A systematic review and meta-analysis (Journal of Substance Use and Addiction Treatment) 

Alcohol 

• The impact of discrimination on alcohol use varies across different groups (Alcohol Research Group) 

• Hazelden doc on why enhanced alcohol warning labels are needed (MinnPost) 

• Minnesota-based group fights stigma surrounding fetal alcohol spectrum disorders (MPR News) 

• How Americans view alcohol’s benefits and risks (Pew Research Center) 

Cannabis 

• Here's what we know about when Minnesota's marijuana dispensaries will open (Axios Twin Cities) 

• If it’s marketed as cannabis, it needs a warning label (American Medical Association) 

• Driving while high is hard to detect. States are racing to find a good tool (MPR News) 

• Why and how we should protect youth in the context of state marijuana legalization (Drug Free) 

Opioids 

• How Hennepin County is combating its recent overdose crisis (CBS Minnesota) 

• Deadliest phase of fentanyl crisis eases, as all states see recovery (MPR News) 

• CDC reports nearly 24% decline in U.S. drug overdose deaths (CDC) 

• Overdose mortality is trending down, but the story is different for elder Black men (The Network for Public Health Law) 

Prescription drugs 

• Co-prescribed stimulants, opioids linked to higher opioid doses (Science Daily) 

Commercial tobacco and e-cigarettes 

• Vaping might cut cigarettes, but won't help smokers quit nicotine for good (Medical News) 

Stimulants 

• Federal government lifts key barrier to stimulant addiction care (Pew Charitable Trust) 

Psychedelic medicine 

• Magic mushrooms warp our sense of space, time, and self by disrupting our brain connections, scientists say (Popular Mechanics) 

• MDMA for active-duty troops: Aaron Wolfgang on DoD’s unprecedented study (Psychedelic Alpha) 

• Psilocybin therapy shows potential for treating clinician depression (Physician’s Weekly) 

• Unveiling the mystical: How scholars are advancing psychedelics study (The Harvard Gazette)